ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666571 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666571; 2) Community: the network communities that were significantly associated with the response to NSC 666571; 3) Molecule: the relationships between components within communities and NSC 666571; 4) MDR: the compounds that were significantly associated with the NSC 666571.

NSC Compound Enrichment Correlation
NSC 100880 Camptothecin 0.0352383000003056 0.086832416
NSC 114346 Null 0.0352383000003056 0.42847683
NSC 135880 Null 0.0352383000003056 0.47771709
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.0352383000003056 0.30232753
NSC 269760 B8 0.0352383000003056 0.28605146
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0352383000003056 0.25383962
NSC 313681 Oxiperomide(USAN) 0.0352383000003056 0.19079115
NSC 339137 PHYSALOLACTONE 0.0352383000003056 0.41296612
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0352383000003056 0.067009914
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0352383000003056 0.29984678
Total:78  Current:55    [First] [Prev] [Next] [Last]